Diabetes Experts Explore Pros And Cons Of Developing Mobile Health Apps
This article was originally published in The Gray Sheet
Mobile health developers looking to enter the diabetes care space face significant challenges, but also have a unique opportunity to address critical user needs, experts said recently.
You may also be interested in...
Assessing early AF intervention
The medical device and software industries voiced support last week for a July 19 FDA draft guidance that helps clarify the types of mobile software applications that would face FDA regulation.
Advances in cloud computing – where data storage or processing tasks for a software application are distributed among multiple remote computer networks – are adding a new wrinkle to industry’s efforts to draft a mobile health regulatory guidance document for FDA review.